← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-11 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
CGTBiologicstaleCity of Hope Medical CenterPhase 1

lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells (lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells)

AIDS-related Non-Hodgkin Lymphoma; AIDS-related Plasmablastic Lymphoma · AIDS-related Non-Hodgkin Lymphoma

#AIDS-relatedNon-HodgkinLymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleCytoDyn, Inc.Preclinical

PRO 140 (leronlimab, leronlimab (PRO 140))

TNBC; TNBC - Triple-Negative Breast Cancer · TNBC

#TNBC#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSeagen Inc.Phase 1

lintuzumab (lintuzumab)

Myelodysplastic Syndrome (MDS) · Myelodysplastic Syndrome (MDS)

#MyelodysplasticSyndromeMDS#Antibody#Phase1#항체#면역항체+2
효능 ORR 14%임상시험 1상태 ACTIVE
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

mCD19-CAR-CD28-CD3-zeta. (anti-CD19 CAR, mCD19-CAR-CD28-CD3-zeta., mCD19-CAR-CD28-CD3-zeta.(anti-CD19 CAR) retroviral vector-transduced allogeneic peripheral blood lymphocytes (PBL))

Hematologic Malignancies; Hematologic Neoplasms · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleLion TCR Pte. Ltd.Phase 1

mRNA HBV/TCR T-cells (mRNA HBV/TCR T-cells)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of MiamiPhase 2

mTOR inhibitor + Selective estrogen receptor modulator (mTOR inhibitor + Selective estrogen receptor modulator)

Breast Cancer; ER-positive Breast Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleKiniksa Pharmaceuticals Interna…Phase 3

mavrilimumab (mavrilimumab)

COVID · COVID

#COVID#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleWeill Medical College of Cornel…Phase 2

mesna, cisplatin, etoposide, rituximab (mesna, cisplatin, etoposide, rituximab)

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 83%임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 2

metoprolol, infliximab, etanercept, tocilizumab and/or other agents (metoprolol, infliximab, etanercept, tocilizumab and/or other agents)

Solid Tumor; Hematological Malignancy · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

miFL + bevacizumab (miFL + bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleBeth ChristianPhase 2

milatuzumab (milatuzumab)

Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 24%임상시험 1상태 ACTIVE
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

monotherapy chemotherapy (monotherapy chemotherapy)

Advanced Solid Tumors; Breast Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 44.4%임상시험 1상태 RECRUITING
AntibodystaleThe Greater Poland Cancer CentrePreclinical

doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab (neoadjuvant treatment, neoadjuvant treatment (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab))

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

RO5072759 (obinutuzumab, obinutuzumab (RO5072759))

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSpanish Cooperative Group for t…Phase 2

durvalumab (Imfinzi, olaparib+durvalumab)

Metastatic Pancreatic Cancer · Metastatic Pancreatic Cancer

#MetastaticPancreaticCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleCentre Georges Francois LeclercPhase 2

durvalumab (Imfinzi, olaparib, durvalumab, tremelimumab)

Immunotherapy · Immunotherapy

#Immunotherapy#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstalePediatric Brain Tumor ConsortiumPhase 1

oncolytic HSV-1716 (oncolytic HSV-1716)

Recurrent Childhood Anaplastic Astrocytoma; Recurrent Childhood Anaplastic Oligoastrocytoma · Recurrent Childhood Anaplastic Astrocyto

#RecurrentChildhoodAnaplasticAstr#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleCG Oncology, Inc.Phase 2

oncolytic adenovirus expressing GMCSF (oncolytic adenovirus expressing GMCSF)

Bladder Cancer; High Grade · Bladder Cancer

#BladderCancer#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 5%임상시험 1상태 DISCONTINUED
AntibodystaleChinese PLA General HospitalPhase 2

oxaliplatin+capecitabine+bevacizumab+PD-1 antibody (oxaliplatin+capecitabine+bevacizumab+PD-1 antibody)

Colorectal Cancer; RAS Mutation · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleDorte NielsenPhase 2

trastuzumab (Herceptin, oxaliplatin, capecitabine, trastuzumab)

Metastatic Breast Cancer; Liver Metastases · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE

172 / 177 페이지

← 이전다음 →